Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07465666) titled 'A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab Emirates' on March 6.
Study Type: Observational
Primary Sponsor: Novartis Pharmaceuticals
Condition:
Hypertension
Recruitment Status: Not recruiting
Date of First Enrollment: April 1, 2026
Target Sample Size: 500
To know more, visit https://clinicaltrials.gov/study/NCT07465666
Published by HT Digital Content Services with permission from Health Daily Digest....